Skip to content

Main Navigation

Cellipont
  • Cell Therapy Services
    • CAR-T Services
    • Allogeneic Cell Therapy
    • Autologous Cell Therapy
    • iPSC Services
    • Exosome Manufacturing
  • Our Capabilities
    • Process Development & Analytical Development
    • Clinical Manufacturing
    • Facility
    • Quality Control
    • Quality & Compliance
  • Facility
  • About
    • Cellipont Bioservices
    • Our History
    • Mission & Values
    • Leadership
  • News & Events
    • Press Releases
    • Events
  • Careers
  • Contact Us

Home » Newsroom

Newsroom

  • News

Want to Learn More About Our Capabilities?

Contact Us

Latest Corporate News

Press Release / September 17, 2026

Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies. Combination creates a scaled U.S. advanced therapies CDMO with broader technical expertise and capabilities from early development through commercial supply.

  RESEARCH TRIANGLE PARK, NC and THE WOODLANDS, TX —  Sept. 17...
Press Release / September 9, 2026

Cellipont Bioservices and Xiogenix Publish New White Paper on Automated Fill-Finish for Scalable Cell Therapy Manufacturing

    The WOODLANDS, Texas and Muskego, Wisconsin. —...
Press Release / September 3, 2026

Cellipont Bioservices’ Texas Facility Has Supported Six Client Projects Expected to Reach IND Submission in 2026

THE WOODLANDS, Texas — September 3, 2026 / Cision / – Cellipont Bioser...
Show More News
Press Inquiry? Send us a message

Upcoming Events & Conferences

Sep 25
Conference

iC³ Life Science and Healthcare Innovation Summit | Sept 24-25 | Dallas TX

Dallas, TX
Oct 7
Conference

MESA | October 5-7, 2026 | Phoenix, AZ

Phoenix, AZ
MESA | October 5-7, 2026 | Phoenix, AZ
View more events >

We bridge your innovative concepts to effective cell therapies for patients.

Contact Us Explore Facility
  • Cell Therapy Services
  • Our Capabilities
  • Facility
  • About
  • News & Events
  • Careers

9501 Lakeside Boulevard, The Woodlands, TX 77381 | +1 (346) 471-6196

Privacy Policy | © 2026 Cellipont Bioservices.